Lawrenceville, NJ, United States of America

Michael J Sofia


Average Co-Inventor Count = 3.3

ph-index = 9

Forward Citations = 224(Granted Patents)


Location History:

  • Carmel, IN (US) (1993 - 1996)
  • Laurenceville, NJ (US) (1997)
  • Lawrenceville, NJ (US) (1992 - 2001)

Company Filing History:


Years Active: 1992-2001

Loading Chart...
20 patents (USPTO):Explore Patents

Title: Michael J. Sofia: Pioneer in Antibiotic Research and Innovation

Introduction: Michael J. Sofia is an accomplished inventor based in Lawrenceville, NJ, USA, known for his significant contributions to the field of antibiotic research. With an impressive portfolio of 20 patents, Sofia has been at the forefront of innovative solutions in medicinal chemistry, particularly in the development of new antibiotic compounds.

Latest Patents: One of Sofia's notable recent patents is titled "Combinatorial Library of Moenomycin Analogs and Methods of Producing Same." This patent pertains to a combinatorial chemical library comprised of compounds that are structurally related to the moenomycin class of antibiotics. The methodology outlined in this patent offers techniques for producing these analogs, which may lead to advancements in antibiotic development.

Career Highlights: Throughout his career, Michael J. Sofia has made substantial strides while working at renowned pharmaceutical companies such as Eli Lilly and Company and E.R. Squibb & Sons, Inc. His expertise has helped shape the direction of research in the pharmaceutical industry, particularly in the quest for new and effective antibiotics.

Collaborations: Sofia has collaborated with several distinguished colleagues, including Ramesh Kakarla and Dashan Liu. These partnerships have enhanced the research endeavors within his projects and contributed to the successful development of new pharmacological compounds.

Conclusion: Michael J. Sofia's contributions to antibiotic research demonstrate his innovative spirit and commitment to advancing medical science. With a strong foundation of patents and collaborations, his work continues to influence the future of antibiotic development and therapeutic solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…